FERRARESI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 3.179
EU - Europa 825
AS - Asia 792
SA - Sud America 116
AF - Africa 9
OC - Oceania 4
Totale 4.925
Nazione #
US - Stati Uniti d'America 3.146
CN - Cina 335
SG - Singapore 303
UA - Ucraina 205
DE - Germania 186
IT - Italia 141
TR - Turchia 114
BR - Brasile 110
GB - Regno Unito 99
FI - Finlandia 61
SE - Svezia 34
CA - Canada 24
BE - Belgio 22
PL - Polonia 14
FR - Francia 12
IN - India 8
CZ - Repubblica Ceca 7
RU - Federazione Russa 7
AT - Austria 6
ID - Indonesia 6
LT - Lituania 6
MX - Messico 6
RO - Romania 6
ZA - Sudafrica 6
HK - Hong Kong 5
IE - Irlanda 5
NL - Olanda 4
IR - Iran 3
UZ - Uzbekistan 3
VN - Vietnam 3
AR - Argentina 2
AU - Australia 2
BD - Bangladesh 2
CO - Colombia 2
DK - Danimarca 2
ES - Italia 2
IQ - Iraq 2
JO - Giordania 2
JP - Giappone 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
LB - Libano 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.925
Città #
Woodbridge 353
Fairfield 313
Chandler 249
Ann Arbor 224
Jacksonville 223
Houston 217
Santa Clara 198
Singapore 166
Ashburn 149
Seattle 143
Wilmington 124
Cambridge 108
Beijing 96
Ferrara 73
Izmir 72
Boardman 71
Nanjing 67
New York 65
Princeton 48
Munich 33
Shanghai 29
Dearborn 23
Shenyang 23
Brussels 22
Milan 22
San Diego 22
Jiaxing 19
Los Angeles 17
Nanchang 16
Bremen 15
Jinan 14
Warsaw 14
Düsseldorf 13
Hebei 13
The Dalles 13
Tianjin 13
Auburn Hills 11
Falls Church 11
London 10
Turku 10
Chicago 9
Ottawa 9
Redwood City 9
Belo Horizonte 8
Nuremberg 8
Bologna 7
Helsinki 7
Mountain View 7
San Mateo 7
Washington 7
Brno 6
Frankfurt am Main 6
Jakarta 6
Norwalk 6
San Francisco 6
Toronto 6
Brooklyn 5
Changsha 5
Florence 5
Mexico City 5
Monmouth Junction 5
Ningbo 5
São Paulo 5
Falkenstein 4
Philadelphia 4
Rio de Janeiro 4
Taizhou 4
Vienna 4
Zhengzhou 4
Ardabil 3
Augusta 3
Curitiba 3
Hong Kong 3
Johannesburg 3
Kunming 3
Lappeenranta 3
Leawood 3
Orange 3
Santo André 3
Tashkent 3
Uberlândia 3
Amman 2
Amsterdam 2
Atlanta 2
Auckland 2
Bovisio-Masciago 2
Brasília 2
Campo Grande 2
Cherasco 2
Chesapeake 2
Copenhagen 2
Cuiabá 2
Dallas 2
Des Moines 2
Dong Ket 2
Dublin 2
Haikou 2
Hefei 2
Hyderabad 2
Indaiatuba 2
Totale 3.569
Nome #
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 166
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 153
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 152
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 146
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 136
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 132
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 130
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 128
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. 125
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 125
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 125
Factor IX propeptide mutation and life threatening bleeding 123
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 122
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 119
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 117
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 117
Next-generation sequencing and recombinant expression characterized aberrant splicing mechanisms and provided correction strategies in factor VII deficiency 116
Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism 111
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report 108
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 107
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 106
null 103
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 103
Factor V gene mutations (R2 gene) are associated with coronary artery disease inelderly people 98
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 97
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 96
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 89
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report 89
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 86
Modulation of FVII levels by intron 7 polymorphisms: population and in vitro studies 85
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 85
Study of a G/A variation in the 3' untranslated region of prothrombin mRNA in Italian patients with venous thrombosis 84
null 82
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 82
Non-conventional therapeutic strategies for inherited disorders of hemostasis 80
Factor VIIa levels, gene polymorphism and plasma lipids in subjects with or without angiographically proven coronary artery disease 79
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 79
null 78
Modulation Of Factor VII Expression By Repeat And Sequence Variations In The Intron 7 Of FVII Gene: Population And In Vitro Studies 78
null 73
Strong contribution of FVII genotypes to activated FVII levels and differences in genotype frequencies in northern and southern European countries 72
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 66
The asymptomatic carriership of thrombophilic defects is associated with frequent genotypes of the fibrinogen gene cluster. 65
null 61
null 61
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 55
In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies 54
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 50
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 48
The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study. 38
Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype 35
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 27
Temporal and genotype-driven variations of factor VII levels in patients with acute myocardial infarction 26
Rescue of a panel of Hemophilia A-causing 5’ss splicing mutations by unique Exon-specific U1snRNA variants 5
Totale 4.973
Categoria #
all - tutte 24.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.664


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 0 0 0 0 11
2020/2021580 59 44 25 66 34 61 28 72 14 71 82 24
2021/2022476 21 55 34 23 21 9 24 15 9 32 62 171
2022/2023525 56 53 16 79 75 79 18 41 63 2 23 20
2023/2024354 31 26 7 6 30 78 10 26 9 19 11 101
2024/20251.054 29 20 115 36 147 128 9 24 163 113 184 86
Totale 4.973